Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Form 3

Who owns the 630,000 Class A shares of "PTSC Sub One"?

Be aware that each Class A share converts in 5,097 and .053 shares (!) - and NOT 5,097,053!

Nicole Steinmetz = 217,000 (she: 161,000 - her husband: 56,000) = normal PTSC shares:
1 billion 106 million 164,010 

Steven King = 161,000 = normal PTSC shares:
820 million 702,330

Paul Lytle = 161,000 = normal PTSC shares:
820 million 702,330

Robert Garnick = 35,000 = normal PTSC shares:
178 million 413,550

2,925982,220 shares in total:
2 billion 925 million 982,220

But who owns the Class B shares of "PTSC Sub One"?

In the fillings it's written:
"As the sole holder of the Series B Preferred Stock the INVESTOR shall receive certain registration rights and information rights, to which the Company has agreed under the SPA."

and the INVESTOR is:

INVESTOR:

CASE WESTERN RESERVE UNIVERSITY

IN WITNESS WHEREOF, the parties have executed this INVESTORS’ RIGHTS AGREEMENT as of the date first written above.

 

    PATRIOT SCIENTIFIC CORPORATION
     
     
By:    
Name:  

Carlton Johnson

Title:   Interim CEO
     
     
   

INVESTOR:

CASE WESTERN RESERVE UNIVERSITY

     
     
By:    
Name:   Michael Haag
Title:  

Executive Director, Technology Management

 

 

   
     
By:    
Name:   Michael Lee
Title:   Treasurer

 

 

 

Share
New Message
Please login to post a reply